The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Danilov A.B.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Il'iasov R.R.

Kafedra khirurgii i éndoskopii Penzenskogo IUV;
kafedra gospital'noĭ khirurgii #1 Pervogo MGMU im. I.M. Sechenova

Sex hormones and pain

Authors:

Danilov A.B., Il'iasov R.R.

More about the authors

Read: 23311 times


To cite this article:

Danilov AB, Il'iasov RR. Sex hormones and pain. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(2):149‑154. (In Russ.)
https://doi.org/10.17116/jnevro201711721149-154

Recommended articles:
Drinking mine­ral water for progressive resi­stance to insu­lin. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(2):24-30
Biofeedback in complex therapy of pain syndromes. Russian Journal of Pain. 2025;(2):70-75

References:

  1. Hassan S, Muere A, Einstein G. et al. Ovarian hormones and chronic pain: A comprehensive review. PAIN. 2014;155(12):2448-2460. doi:10.1016/j.pain.2014.08.027
  2. Chlebowski T, Cirillo J. Estrogen alone and joint symptoms in the Women’s Health Initiative randomized trial. Menopause. 2013;20(6):600-608. doi:10.1097/GME.0b013e31828392c4
  3. Dohle G, Arver S, Bettocchi C. et al. Guidelines on male hypogonadism. EAU. 2015;24. Available at: http://uroweb.org/wp-content/uploads/18-Male-Hypogonadism_LR1.pdf
  4. Dedov II, Kalinchenko SYu. Androgen deficiency in the ageing men. Practical Medicine; 2006. (In Russ.).
  5. Stellato R, Feldman H, Hamdy O. Testosterone, sex hormone-binding globulin,and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 2000;23:490-494. doi:10.2337/diacare.23.4.490
  6. Kupelian V, Shabsigh R, Araujo A. Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study. J Urol. 2006;176:222-226. doi:10.1016/S0022-5347(06)00503-9
  7. Tajar A, Huhtaniemi I, O’Neill T et al. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab. 2012;97(5):1508-1516. doi:10.1210/jc.2011-2513
  8. Tyuzikov IA. Results of pilot epidemiological study of androgen deficiency prevalence at men in ambulance practice of various specialities’ doctors (Yaroslavl study). Andrologiya i genital'naya khirurgiya. 2013;3:23-28. (In Russ.). doi:10.17650/2070-9781-2013-3-23-28
  9. Berkley KJ. Sex differences in pain. Behav Brain Sci. 1997;20(3):371-380. doi:10.1017/s0140525x97221485
  10. Kravchenko АYa, Provotorov VM. Clinical effect of testosterone in men with stable angina. Rational Pharmacother Card. 2009;1:10-13. (In Russ.). Available at: http://cyberleninka.ru/article/n/klinicheskiy-effekt-testosterona-pri-stabilnoy-stenokardii-u-muzhchin.pdf
  11. Coulombe MA. Estrogen receptors beta and alpha have specific pro- and antinociceptive actions. Neuroscience. 2011;184:172-182. doi:10.1016/j.neuroscience.2011.02.057
  12. Cao DY, Ji Y, Tang B, Traub RJ. Estrogen receptor β activation is antinociceptive in a model of visceral pain in the rat. J Pain. 2012;13(7):685-694. doi:10.1016/j.jpain.2012.04.010
  13. Ashcroft GS. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med. 1997;3(11):1209-1215. doi:10.1038/nm1197-1209
  14. Unruh AM. Gender variations in clinical pain experience. PAIN. 1996;65:123-167. doi:10.1016/0304-3959(95)00214-6
  15. Ashburn MA, Staats PS. Management of chronic pain. Lancet. 1999;353:1865-1869. doi:10.1016/S0140-6736(99)04088-X
  16. Schaible HG, Richter F. Pathophysiology of pain. Langenbecks Arch Surg. 2004;389:237-243. doi:10.1007/s00423-004-0468-9
  17. Fillingim RB, Ness TJ. Sex-related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev. 2000;24:485-501. doi:10.1016/s0149-7634(00)00017-8
  18. Riley 3rd JL, Robinson ME, Wise EA, Myers CD, Fillingim RB. Sex differences in the perception of noxious experimental stimuli: a meta-analysis. PAIN. 1998;74:181-187. doi:10.1016/s0304-3959(97)00199-1
  19. Reshetnjak VK. Gendernye razlichija korkovo-podkorkovyh struktur mozga, uchastvujushhih v vosprijatii boli.Rossijskij zhurnal boli. 2014;42(1):20-21.(In Russ.). Available at: http://painrussia.ru/upload/iblock/761/7610b1b67886e884dc6297ec8b9e09db.pdf
  20. Chaia N, Peterlina L, Calhounb H. Migraine and estrogen. Curr Opin Neurol. 2014;27(3):315-324. doi:10.1097/wco.0000000000000091
  21. Danilov AB. Rol' pola i gendera pri migreni i golovnoi boli napryazheniya (kliniko-psikhoneirofiziologicheskoe issledovanie): Dis. d-ra med. nauk. M. 2007. (In Russ.).
  22. MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology. 2004;63:351-353. doi:10.1212/01.wnl.0000133134.68143.2e
  23. Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000;55:1517-1523. doi:10.1212/wnl.55.10.1517
  24. Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M. Sex hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia. 1995;15:140-144. doi:10.1046/j.1468-2982.1995.015002140.x
  25. Glaser R, Dimitrakakis C, Trimble N, Martin V. Testosterone pellet implants and migraine headaches: a pilot study. Maturitas. 2012;71(4):385-388. doi:10.1016/j.maturitas.2012.01.006
  26. Cairns E, Gazerani P. Sex-related differences in pain. Maturitas. 2009;63:292-296. doi:10.1016/j.maturitas.2009.06.004
  27. Anderberg UM, Marteinsdottir I, Hallman J, Ekselius L, Backstrom T. Symptom perception in relation to hormonal status in female fibromyalgia syndrome patients. J Musculoskelet Pain. 1999;7:21-38. doi:10.1300/j094v07n03_03
  28. Pamuk ON, Cakir N. The variation in chronic widespread pain and other symptoms in fibromyalgia patients. The effects of menses and menopause. Clin Exp Rheumatol. 2005;23:778-782. Available at: http://www.clinexprheumatol.org/article.asp?a=2740
  29. Ostensen M, Rugelsjoen A, Wigers SH. The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol. 1997;26:355-360. doi:10.3109/03009749709065698
  30. Latman NS. Relation of menstrual cycle phase to symptoms of rheumatoid arthritis. Am J Med. 1983;74:957-960. doi:10.1016/0002-9343(83)90789-1
  31. Fischer L, Clemente JT, Tambeli CH. The protective role of testosterone in the development of temporomandibular joint pain. Pain. 2007;8(5):437-442. doi:10.1016/j.jpain.2006.12.007
  32. Hofbauer L, Khosla. Androgen effects on bone mineral metabolism: recent progress and controversies. Eur J Endocrinol. 1999;140:271-286. doi:10.1530/eje.0.1400271
  33. Hajati AK, Alstergren P, Näsström K, Bratt J, Kopp S. Endogenous glutamate in association with inflammatory and hormonal factors modulates bone tissue resorption of the temporomandibular joint in patients with early rheumatoid arthritis. J Oral Maxillofac Surg. 2009;67(9):1895-1903. doi:10.1016/j.joms.2009.04.056
  34. Burduli AG, Smetnik VP. Androgens and bone. Russian Journal of Human Reproduction. 2011;5:110-115. (In Russ.). Available at: http://www.mediasphera.ru/uppic/Reproduction/2011/5/23/REP_2011_05_110.pdf
  35. Vincent A. Prevalence of fibromyalgia: A population-based study in Olmsted County, Minnesota, utilizting the Rochester Epidemiology project. Arthritis care and research. 2013;65(5):786-792. doi:10.1002/acr.21896
  36. Castro-Sanchez AM. Gender differences in pain severity, disability, depression, and widespread pessure pain sensitivity in patients with fibromyalgia syndrome without comorbid conditions. Pain medicine. 2012;13(12):1639-1647. doi:10.1111/j.1526-4637.2012.01523.x
  37. White D. Treatment of pain in fibromyalgia patientswith testosterone gel: Pharmacokinetics and clinical response. International Immunopharmacology. 2015;27(2):249-256. doi:10.1016/j.intimp.2015.05.016
  38. Straub R. Нormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J Clin Endocrinol Metab. 2000;85(3):1340-1344. doi:10.1210/jc.85.3.1340
  39. Afzal S, Khanam A. Serum estrogen and interleukin-6 levels in postmenopausal female osteoarthritis patients. Pak J Pharm Sci. 2011;24(2):217-219.
  40. Cutolo M, Calva A. Sex steroids and immunity. Psychoneuroimmunology. 2007;9(1):207-216. doi:10.1016/B978-012088576-3/50013-7
  41. Rudge SR, Kowanko IC, Drury PL. Menstrual cyclicity of finger joint size and grip strength in patients with rheumatoid arthritis. Ann Rheum Dis. 1983;42:425-430. doi:10.1136/ard.42.4.425
  42. Hellstrom B, Anderberg UM. Pain perception across the menstrual cycle phases in women with chronic pain. Percept Mot Skills. 2003;96:201-211. doi:10.2466/pms.2003.96.1.201
  43. Kaergaard A, Hansen AM, Rasmussen K, Andersen JH. Association between plasma testosterone and work-related neck and shoulder disorders among female workers. Scand J Work Environ Health. 2000;26(4):292-298. doi:10.5271/sjweh.545
  44. Wiholm C, Arnetz B. Stress management and musculoskeletal disorders in knowledge workers: the possible mediating effects of stress hormones. Advances in Physiotherapy. 2006;8(1):5-14. doi:10.1080/14038190500494683
  45. Anderson K, Tuetken R, Hoffman V. A potential relationship between diffuse musculoskeletal pain and hypogonadism. BMJ Case Rep. 2010;34:67-70. doi:10.1136/bcr.08.2009.2152
  46. Meleine M. Gender-related differences in irritable bowel syndrome: Potential mechanisms of sex hormones. WJG. 2014;20(22):6725-6743. doi:10.3748/wjg.v20.i22.6725
  47. Matheis A, Martens U, Kruse J, Enck P. Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome? World J Gastroenterol. 2007;13:3446-3455. doi:10.3748/wjg.v13.i25.3446
  48. Vercellini P, Somigliana E, Vigano P, Abbiati A, Barbara G, Fedele L. Chronic pelvic pain in women: etiology, pathogenesis and diagnostic approach. Gynecol Endocrinol. 2009;25:149-158. doi:10.1080/09513590802549858
  49. Houghton LA, Jackson NA, Whorwell PJ, Morris J. Do Male Sex Hormones Protect From Irritable Bowel Syndrome? Am J Gastroenterol. 2000;95(9):2296-3000. doi:10.1111/j.1572- 0241. 2000. 02314.x
  50. Malkin C, Pugh P, Jones R. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004;89:3313-3318. doi:10.1210/jc.2003-031069
  51. Tishova Y, Mskhalaya G, Saad F, Kalinchenko S. Effect of testosterone treatment on inflammatory markers in men with late-onsethypogonadism (LOH) and metabolic syndrome (MS). Journal of Men's Health and Gender. 2013;4(3):366-366. doi:10.1016/j.jmhg.2007.07.017
  52. Pontari A, Ruggieri R. Mechanisms in Prostatitis/Chronic Pelvic Pain Syndrome. J Urol. 2008;179(5):61-67. doi:10.1016/j.juro.2008.03.139
  53. Kurbatov DG, Kuznetskiy YY, Rozhivanov RV, Dubskiy SA. The use of testosterone in combination therapy of patients with chronic pelvic pain syndrome and androgenic deficit. Vestnik reproduktivnogo zdorov'ya 2008;3-4:39-44. (In Russ.). doi:10.14341/brh20083-439-44
  54. Okifuji А, Hare D.The association between chronic pain and obesity. J Pain Res. 2015;8:399-408. doi:10.2147/JPR.S55598
  55. Vodo S, Bechi Ni, Petroni A. Testosterone-Induced Effects on Lipids and Inflammation. Mediators of Inflammation. 2013;11:78-81. doi:/10.1155/2013/183041
  56. Bagatell C, Knopp R, Vale W. Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels. Annals of Internal Medicine. 1992;116(12):967-973. doi:10.7326/0003-4819-116-12-967
  57. Trayhurn P, Wood I. Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition. 2004;92(3):347-355. doi:10.1079/BJN20041213
  58. Maggio M, Basaria S, Ceda G. Correlation between testosterone and the inflammatory marker soluble Interleukin-6 receptor in older men. The Journal of Clinical Endocrinology & Metabolism. 2005;91(1):345-347. doi:10.1210/jc.2005-1097

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.